- $114.95m
- -$63.14m
- $150.11m
- 63
- 62
- 36
- 53
2019 December 31st | R2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 8-K |
Standards: | USG | USG | USG | USG | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 120 | 229 | 380 | 270 | 150 |
Cost of Revenue | |||||
Gross Profit | 114 | 217 | 355 | 239 | 135 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 145 | 332 | 674 | 691 | 254 |
Operating Profit | -24.8 | -103 | -294 | -421 | -104 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -23.6 | -149 | -207 | -439 | -106 |
Provision for Income Taxes | |||||
Net Income After Taxes | -23.6 | -149 | -188 | -439 | -107 |
Net Income Before Extraordinary Items | |||||
Net Income | -23.6 | -149 | -188 | -439 | -107 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -23.6 | -149 | -188 | -439 | -107 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.72 | -9.76 | -9.28 | -15.9 | -5.48 |